These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3708585)

  • 21. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential antitumor agents XIX [1]. Synthesis and antitumor activity of tricyclic compounds related to lotifazole.
    Andreani A; Rambaldi M; Locatelli A; Fraccari A; Bossa R; Galatulas I
    Pharm Acta Helv; 1992; 67(8):234-6. PubMed ID: 1384067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of patulin and structural analogs.
    Seigle-Murandi F; Steiman R; Krivobok S; Beriel H; Benoit-Guyod JL
    Pharmazie; 1992 Apr; 47(4):288-91. PubMed ID: 1518888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.
    Narumiya S; Ohno K; Fukushima M; Fujiwara M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):306-11. PubMed ID: 3302206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
    Narumiya S; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
    Elo HO; Lumme PO
    Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of lipid microspheres as a drug carrier for antitumour drugs.
    Mizushima Y; Shoji Y; Kato T; Fukushima M; Kurozumi S
    J Pharm Pharmacol; 1986 Feb; 38(2):132-4. PubMed ID: 2870158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1.
    Bregman MD; Meyskens FL
    Cancer Res; 1983 Apr; 43(4):1642-5. PubMed ID: 6572555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
    Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
    J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
    Lacal PM; Puglianiello A; Bonmassar E; D'Onofrio C
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1086-95. PubMed ID: 7965770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells.
    Sakai T; Aoike A; Marui N; Kawai K; Nishino H; Fukushima M
    Cancer Res; 1989 Mar; 49(5):1193-6. PubMed ID: 2917351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of 17 beta-hydroxy-3-aza-A-homo-4 alpha-androsten-4-one-p-N, N-bis(2-chloroethyl)aminophenoxyacetate (NSC-620480) in P388 leukemia. Activity of steroidal lactams in Ehrlich tumor.
    Catsoulacos P; Pairas G
    Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):501-5. PubMed ID: 2087151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.